Gene Oasis

Gene Oasis is a Singapore-based biotechnology group specializing in the research, development, and commercialization of cellular wellness solutions, regenerative medicine, and natural bioactive ingredients. Founded by a group of scientists, the company has evolved from a focus on proprietary bird's nest processing and bioactive extraction into a diversified biotech incubator and developer. Its core expertise spans stem cell therapy, induced pluripotent stem cells (iPSC), and precision diagnostics. The company operates through a complex ecosystem of subsidiaries and spin-offs, including GO BioEnterprise (commercial arm), GO-Dx (diagnostics), and specialized therapeutic entities like FEGO Cell Therapies and NGF. Gene Oasis leverages a strong portfolio of intellectual property, particularly in the fields of peptide extraction and stem cell culture, to address major health challenges such as oncology, neurodegenerative diseases, and metabolic disorders. It is currently positioning itself for international expansion with a focus on the US and Middle Eastern markets.